{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:10:24Z","timestamp":1787314224661,"version":"build-2736575974"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Observational studies link high midlife systolic blood pressure to increased dementia risk. However, the synthesis of evidence from randomized controlled trials has not definitively demonstrated that antihypertensive medication use reduces dementia risk. Here, we emulate target trials of antihypertensive medication initiation on incident dementia using three cohort studies, with attention to potential violations of necessary assumptions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We emulated trials of antihypertensive medication initiation on incident dementia using data from the Atherosclerosis Risk in Communities study, Cardiovascular Health Study, and Health and Retirement Study. We used data-driven methods to restrict participants to initiators and noninitiators with overlap in propensity scores and positive control outcomes to look for violations of positivity and exchangeability assumptions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Analyses were limited by the small number of cohort participants who met eligibility criteria. Associations between antihypertensive medication initiation and incident dementia were inconsistent and imprecise (Atherosclerosis Risk in Communities: HR = 0.30 [0.05, 1.93]; Cardiovascular Health Study: HR = 0.66 [0.27, 1.64]; Health and Retirement Study: HR = 1.09 [0.75, 1.59]). More stringent propensity score restrictions had little effect on findings. Sensitivity analyses using a positive control outcome unexpectedly suggested antihypertensive medication initiation increased the risk of coronary heart disease in all three samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Positive control outcome analyses suggested substantial residual confounding in effect estimates from our target trials, precluding conclusions about the impact of antihypertensive medication initiation on dementia risk through target trial emulation. Formalized processes for identifying violations of necessary assumptions will strengthen confidence in target trial emulation and avoid inappropriate confidence in emulated trial results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ede.0000000000001802","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T12:04:26Z","timestamp":1727784266000},"page":"48-59","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Target Trial Emulation Using Cohort Studies: Estimating the Effect of Antihypertensive Medication Initiation on Incident Dementia"],"prefix":"10.1097","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4195-042X","authenticated-orcid":false,"given":"Erin E.","family":"Bennett","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma K.","family":"Stapp","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan Z.","family":"Gianattasio","sequence":"additional","affiliation":[{"name":"Department of Health Care Evaluation, NORC at the University of Chicago, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Zimmerman","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingkai","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Griswold","sequence":"additional","affiliation":[{"name":"Memory Impairment and Neurodegenerative Dementia Center, University of Mississippi Medical Center, Jackson, MS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette L.","family":"Fitzpatrick","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, School of Medicine, University of Washington, Seattle, WA"},{"name":"Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca F.","family":"Gottesman","sequence":"additional","affiliation":[{"name":"National Institute of Neurological Disorders and Stroke, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenore J.","family":"Launer","sequence":"additional","affiliation":[{"name":"Laboratory of Epidemiology and Population Sciences, National Institute of Aging, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Gwen","family":"Windham","sequence":"additional","affiliation":[{"name":"Memory Impairment and Neurodegenerative Dementia Center, University of Mississippi Medical Center, Jackson, MS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Levine","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, University of Michigan, Ann Arbor, MI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison E.","family":"Fohner","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Maria","family":"Glymour","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda C.","family":"Power","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"R1-20250228","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/jamaneurol.2020.0568","article-title":"Association between blood pressure and later-life cognition among black and white individuals.","volume":"77","author":"Levine","year":"2020","journal-title":"JAMA Neurol"},{"key":"R2-20250228","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/HYPERTENSIONAHA.120.14993","article-title":"Blood pressure and risks of cognitive impairment and dementia.","volume":"76","author":"Ou","year":"2020","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"key":"R3-20250228","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1474-4422(05)70141-1","article-title":"The age-dependent relation of blood pressure to cognitive function and dementia.","volume":"4","author":"Qiu","year":"2005","journal-title":"Lancet Neurol"},{"key":"R4-20250228","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jamaneurol.2017.1658","article-title":"Associations between midlife vascular risk factors and 25-year incident dementia in the atherosclerosis risk in communities (ARIC) cohort.","volume":"74","author":"Gottesman","year":"2017","journal-title":"JAMA Neurol"},{"key":"R5-20250228","first-page":"CD004034","article-title":"Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia.","volume":"2009","author":"McGuinness","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20250228","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2020.4249","article-title":"Association of blood pressure lowering with incident dementia or cognitive impairment: a systematic review and meta-analysis.","volume":"323","author":"Hughes","year":"2020","journal-title":"JAMA"},{"key":"R7-20250228","doi-asserted-by":"crossref","first-page":"e2134553","DOI":"10.1001\/jamanetworkopen.2021.34553","article-title":"Evaluation of intensive vs standard blood pressure reduction and association with cognitive decline and dementia: a systematic review and meta-analysis.","volume":"4","author":"Dallaire-Th\u00e9roux","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R8-20250228","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial.","volume":"321","year":"2019","journal-title":"JAMA"},{"key":"R9-20250228","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/epirev\/mxac002","article-title":"Closing the gap between observational research and randomized controlled trials for prevention of Alzheimer\u2019s disease and dementia.","volume":"44","author":"Power","year":"2022","journal-title":"Epidemiol Rev"},{"key":"R10-20250228","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available.","volume":"183","author":"Hernan","year":"2016","journal-title":"Am J Epidemiol"},{"key":"R11-20250228","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.jacc.2021.04.035","article-title":"The ARIC (Atherosclerosis Risk In Communities) study: JACC focus seminar 3\/8.","volume":"77","author":"Wright","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R12-20250228","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/1047-2797(91)90005-W","article-title":"The cardiovascular health study: design and rationale.","volume":"1","author":"Fried","year":"1991","journal-title":"Ann Epidemiol"},{"key":"R13-20250228","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000067110","article-title":"Evaluation of dementia in the cardiovascular health cognition study.","volume":"22","author":"Lopez","year":"2003","journal-title":"Neuroepidemiology"},{"key":"R14-20250228","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1532-5415.2004.52058.x","article-title":"Incidence and prevalence of dementia in the Cardiovascular Health Study.","volume":"52","author":"Fitzpatrick","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"R15-20250228","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ije\/dyu067","article-title":"Cohort profile: the health and retirement study (HRS).","volume":"43","author":"Sonnega","year":"2014","journal-title":"Int J Epidemiol"},{"key":"R16-20250228","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.2307\/146277","article-title":"An overview of the health and retirement study.","volume":"30","author":"Juster","year":"1995","journal-title":"J Hum Resour"},{"key":"R17-20250228","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet (London, England)"},{"key":"R18-20250228","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial.","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurol"},{"key":"R19-20250228","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.","volume":"163","author":"Tzourio","year":"2003","journal-title":"Arch Intern Med"},{"key":"R20-20250228","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","article-title":"The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial.","volume":"21","author":"Lithell","year":"2003","journal-title":"J Hypertens"},{"key":"R21-20250228","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.","volume":"162","author":"Forette","year":"2002","journal-title":"Arch Intern Med"},{"key":"R22-20250228","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","article-title":"Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.","volume":"352","author":"Forette","year":"1998","journal-title":"Lancet (London, England)"},{"key":"R23-20250228","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.","volume":"372","author":"Yusuf","year":"2008","journal-title":"Lancet"},{"key":"R24-20250228","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(10)70250-7","article-title":"Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.","volume":"10","author":"Anderson","year":"2011","journal-title":"Lancet Neurol"},{"key":"R25-20250228","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"R26-20250228","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults.","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R27-20250228","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects.","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"R28-20250228","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/aje\/kwp436","article-title":"Invited commentary: positivity in practice.","volume":"171","author":"Westreich","year":"2010","journal-title":"Am J Epidemiol"},{"key":"R29-20250228","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/aje\/kwab041","article-title":"Propensity score weighting and trimming strategies for reducing variance and bias of treatment effect estimates: a simulation study.","volume":"190","author":"St\u00fcrmer","year":"2021","journal-title":"Am J Epidemiol"},{"key":"R30-20250228","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"R31-20250228","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(00)03307-9","article-title":"Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials.","volume":"356","year":"2000","journal-title":"Lancet (London, England)"},{"key":"R32-20250228","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","article-title":"Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.","volume":"11","author":"Hernan","year":"2000","journal-title":"Epidemiology"},{"key":"R33-20250228","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/EDE.0b013e318230e861","article-title":"Accounting for bias due to selective attrition: the example of smoking and cognitive decline.","volume":"23","author":"Weuve","year":"2012","journal-title":"Epidemiology"},{"key":"R34-20250228","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"R35-20250228","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting\u2013enzyme inhibitor, Ramipril, on cardiovascular events in high-risk patients.","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"R36-20250228","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/ajh.2011.154","article-title":"Predictors of blood pressure control among hypertensives in community health centers.","volume":"24","author":"Shelley","year":"2011","journal-title":"Am J Hypertens"},{"key":"R37-20250228","doi-asserted-by":"crossref","first-page":"e18174","DOI":"10.1371\/journal.pone.0018174","article-title":"Weight trimming and propensity score weighting.","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"key":"R38-20250228","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jclinepi.2005.07.004","article-title":"A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.","volume":"59","author":"St\u00fcrmer","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"R39-20250228","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/biomet\/asn055","article-title":"Dealing with limited overlap in estimation of average treatment effects.","volume":"96","author":"Crump","year":"2009","journal-title":"Biometrika"},{"key":"R40-20250228","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MLR.0000000000000640","article-title":"Utilization of positive and negative controls to examine comorbid associations in observational database studies.","volume":"55","author":"Desai","year":"2017","journal-title":"Med Care"},{"key":"R41-20250228","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1001\/jama.2023.4221","article-title":"Emulation of randomized clinical trials with nonrandomized database analyses: results of 32 clinical trials.","volume":"329","author":"Wang","year":"2023","journal-title":"JAMA"},{"key":"R42-20250228","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2009.03.001","article-title":"A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies.","volume":"63","author":"Bosco","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"R43-20250228","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/pds.4846","article-title":"Comparison of alternative approaches to trim subjects in the tails of the propensity score distribution.","volume":"28","author":"Glynn","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R44-20250228","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1146\/annurev-statistics-022513-115645","article-title":"A systematic statistical approach to evaluating evidence from observational studies.","volume":"1","author":"Madigan","year":"2014","journal-title":"Annu Rev Stat Appl"},{"key":"R45-20250228","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1097\/MLR.0b013e318074ce79","article-title":"Use of propensity score technique to account for exposure-related covariates: an example and lesson.","volume":"45","author":"Seeger","year":"2007","journal-title":"Med Care"},{"key":"R46-20250228","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension global hypertension practice guidelines.","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"key":"R47-20250228","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1093\/eurheartj\/ehac432","article-title":"Harmonization of the American College of Cardiology\/American Heart Association and European Society of Cardiology\/European Society of Hypertension Blood Pressure\/Hypertension Guidelines: Comparisons, Reflections, and Recommendations.","volume":"43","author":"Whelton","year":"2022","journal-title":"Eur Heart J"},{"key":"R48-20250228","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/sim.2739","article-title":"The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials.","volume":"26","author":"Rubin","year":"2007","journal-title":"Stat Med"},{"key":"R49-20250228","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11883-004-0056-z","article-title":"Cardiovascular risk factors and Alzheimer\u2019s disease.","volume":"6","author":"Luchsinger","year":"2004","journal-title":"Curr Atheroscler Rep"},{"key":"R50-20250228","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/jnc.14132","article-title":"Dementia risk and prevention by targeting modifiable vascular risk factors.","volume":"144","author":"Tariq","year":"2018","journal-title":"J Neurochem"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T16:02:20Z","timestamp":1740758540000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001802","relation":{},"ISSN":["1044-3983","1531-5487"],"issn-type":[{"value":"1044-3983","type":"print"},{"value":"1531-5487","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}